Crypto World

Zepbound Maker Eli Lilly Is In A Race with Novo Nordisk But Its Stock Is The Clear

Published

2 hours ago

on

Zepbound maker and drug giant Eli Lilly’s (LLY) stock is in the buy zone of a flat base after hitting a new high. The IBD Sector Leaders name is in a race with Novo Nordisk (NVO) in the fast-growing weight-loss medication industry. Lilly makes injectable obesity drug Zepbound and Type 2 diabetes treatment Mounjaro. It launched its weight-loss pill Foundayo in…

Copyright ©2026 Investor’s Business Daily, LLC. All rights reserved. 87990cbe856818d5eddac44c7b1cdeb8

Source link

Related Topics:

You must be logged in to post a comment Login

Leave a Reply

Cancel reply

Trending

Exit mobile version